The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment.
Triantafillidis
John K
JK
Gikas
Aristofanis
A
Apostolidiss
Nicolaos
N
Merikas
Emmanuel
E
Mallass
Elias
E
Peros
George
G
D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016022:Case-Control Studies; D016001:Confidence Intervals; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D016015:Logistic Models; D008297:Male; D016017:Odds Ratio; D015995:Prevalence
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents